Seminars in Liver Disease

Papers
(The TQCC of Seminars in Liver Disease is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Critical Care Management of Acute-on-Chronic Liver Failure: Certainties and Unknowns82
Liver Immunology, Immunotherapy, and Liver Cancers: Time for a Rethink?42
A Precision Medicine Guided Approach to the Utilization of Biomarkers in MASLD33
Hepatic Extracellular Matrix and Its Role in the Regulation of Liver Phenotype33
Tight Junction Proteins as Therapeutic Targets to Treat Liver Fibrosis and Hepatocellular Carcinoma32
Patient-Reported Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease27
HBV Biomarkers and Their Role in Guiding Treatment Decisions26
Tailored Model of Care for Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease25
Genetic and Epigenetic Basis of Drug-Induced Liver Injury24
Emerging Targets for the Treatment of Primary Sclerosing Cholangitis23
Genetic Contributions to Biliary Atresia: A Developmental Cholangiopathy18
Growth Hormone Signaling in Liver Diseases: Therapeutic Potentials and Controversies18
Alcohol Plus Additional Risk Factors: Rodent Model of Liver Injury17
Wilson Disease: Novel Diagnostic and Therapeutic Approaches16
Role of YAP1 Signaling in Biliary Development, Repair, and Disease16
Mice Engrafted with Human Liver Cells16
Physiomimetic In Vitro Human Models for Viral Infection in the Liver14
Dietary Recommendations for the Management of Non-alcoholic Fatty Liver Disease (NAFLD): A Nutritional Geometry Perspective14
Diagnosis and Management of Early Stages of ALD13
A Global Systematic Review of Hepatitis C Elimination Efforts through Micro-Elimination12
Circadian Regulation of Gene Expression and Metabolism in the Liver11
11
Role of Intestinal Barrier Disruption to Acute-on-Chronic Liver Failure10
To TIPS or Not to TIPS in High Risk of Variceal Rebleeding and Acute-on-Chronic Liver Failure10
Liver Neurobiology: Regulation of Liver Functions by the Nervous System10
Patient-Centered Treatment of Cirrhosis9
Role of Complement in Liver Diseases9
9
Primary Cilia in Hepatic Biliary Hyperplasia: Implications for Liver Diseases9
Combined hepatocellular-cholangiocarcinoma: a clinical and molecular review8
8
Novel Biomarkers of AKI in Cirrhosis8
Hepatitis Delta Infection: A Clinical Review8
Management of Portal vein Thrombosis in Cirrhosis8
Endoscopic Advances in Hepatology8
Mesenchymal Stem Cell Transplantation in Liver Diseases8
Liver Transplantation for Hepatocellular Carcinoma: A Narrative Review and A Glimpse into The Future8
This Is What Metabolic Dysfunction–Associated Steatotic Liver Disease Looks Like: Potential of a Multiparametric MRI Protocol8
Hepatocellular Carcinoma Chemoprevention with Generic Agents8
LncRNAs, RNA Therapeutics, and Emerging Technologies in Liver Pathobiology7
Pediatric and Adult Liver Disease in Alpha-1 Antitrypsin Deficiency7
Extracellular Vesicles and Micro-RNAs in Liver Disease7
The Hepatic Porphyrias: Revealing the Complexities of a Rare Disease7
Big Data Analytics in Large Cohorts: Opportunities and Challenges for Research in Hepatology7
Erratum to: Genetic Contributions to Biliary Atresia: A Developmental Cholangiopathy7
Noninvasive Tests to Assess Fibrosis and Disease Severity in Metabolic Dysfunction-Associated Steatotic Liver Disease7
Metabolic Injury of Hepatocytes Promotes Progression of NAFLD and AALD7
0.35695791244507